Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Anderson

Showing results (341-350 of 407) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to IIIS L Wolden, J R Anderson, W M Crist, et al.
The Quarterly Journal of Medicine|July 1, 1989
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985R G Watson, C F Johnston, M M O'Hare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicityJ M Vose, P J Bierman, J R Anderson, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group BD B Duggan, M T Santarelli, K Zamkoff, et al.
BJS Open|December 14, 2019
Video-assisted thoracoscopic surgery for ectopic mediastinal parathyroid adenomaK E Isaacs, S Belete, B J Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group BV Vinciguerra, K J Propert, M Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification ProjectT Rüdiger, D D Weisenburger, J R Anderson, et al.
Journal of Personality and Social Psychology|April 1, 1991
The will and the ways: development and validation of an individual-differences measure of hopeC R Snyder, C Harris, J R Anderson, et al.
Pageof 41

Showing results (341-350 of 407) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to IIIS L Wolden, J R Anderson, W M Crist, et al.
The Quarterly Journal of Medicine|July 1, 1989
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985R G Watson, C F Johnston, M M O'Hare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicityJ M Vose, P J Bierman, J R Anderson, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group BD B Duggan, M T Santarelli, K Zamkoff, et al.
BJS Open|December 14, 2019
Video-assisted thoracoscopic surgery for ectopic mediastinal parathyroid adenomaK E Isaacs, S Belete, B J Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group BV Vinciguerra, K J Propert, M Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification ProjectT Rüdiger, D D Weisenburger, J R Anderson, et al.
Journal of Personality and Social Psychology|April 1, 1991
The will and the ways: development and validation of an individual-differences measure of hopeC R Snyder, C Harris, J R Anderson, et al.
Pageof 41